Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Prolacta Bioscience
Entity

Prolacta Bioscience

Tracked across 1 events · 7 articles · First seen Feb 18, 2026 · Last active Feb 19, 2026

Sentiment
80
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 80
Regulatory
Japan Approves Prolacta Bioscience's PreemieFort as Prescription Drug
Prolacta Bioscience received prescription drug approval in Japan for its PreemieFort Enteral Solution, a 100% human milk-based fortifier. This approval is a significant regulatory milestone, validating the company's products and setting a precedent for neonatal intensive care units worldwide. It is expected to boost the company's market position and revenue.
Feb 18, 2026 · 7 articles
NEWSDESK
Track Prolacta Bioscience live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.